Life expectancy at birth in the EU was 81.5 years in 2024, a 0.1-year increase from 2023, following decreases in 2020 (80.4 years) and 2021 (80.1 years) due to the COVID-19 pandemic.
— last modified 21 September 2022 As part of the EU Cancer Screening Scheme to be put forward under Europe’s Beating Cancer Plan, the European Commission presented on 21 September…
— last modified 25 May 2022 As of 26 May, new rules on in vitro diagnostic medical devices (IVDR) such as HIV tests, pregnancy tests or COVID-19 tests, are applicable.Advertisement1.…
— last modified 13 December 2021 The Regulation on Health Technology Assessment (HTA), a deliverable of the EU Pharmaceutical Strategy, was adopted on 13 December.AdvertisementWhat is Health Technology Assessment (HTA)?Health…
— last modified 20 September 2021 The European Commission is launching the European Health Emergency preparedness and Response Authority (HERA) to prevent, detect, and rapidly respond to health emergencies. HERA…
— last modified 26 May 2021 As of 26 May, new EU rules on medical devices (MDR) enter into application, establishing a modern and more robust regulatory framework to protect…
— last modified 26 March 2021 The EU4Health programme came into force on 26 March, making EUR 5.1 billion available to strengthen the resilience of Europe’s health systems and promote…
